Various experiments have evaluated the effect of plk1 knockdown on bladder cancer cells, reporting a reduction in bub1b and an increase in fbxo5 levels as a consequence of plk1 down-regulation. The gene discussed is PLK1; the disease is urinary bladder carcinoma.